Approvals/NMPA/Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine

Approved

生物制品

Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine

Merck, Inc.🇨🇳 National Medical Products Administration

Approval Id: 8G5JDR2dhQo
Approval Number: 国药准字SJ20170038
Generic Name: 四价人乳头瘤病毒疫苗(酿酒酵母)
Generic Name En: Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine
Trade Name: 佳达修
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 0.5mL/瓶（西林瓶）
Reg Date: 2022-04-07
Expired Date: 2027-04-06
Company Name: Merck, Inc.
Production Company Name: Merck, Inc.
Company Detail Path: /organization/merck-inc
Production Company Detail Path: /organization/merck-inc

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 7, 2022

Approval ID

8G5JDR2dhQo

Type

生物制品